Literature DB >> 16770645

Absence of CYP2B6 promoter -82T>C mutation in Chinese as an additional factor for slow metabolism of drugs commonly used in infections.

Ming-Liang He1, Ck Lin, Kenneth Tong, Bingying Xu, Joseph Jy Sung, Hsiang-Fu Kung, Shui-Shan Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16770645     DOI： 10.1007/s00228-006-0163-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  The implications of a high allelic frequency of CYP2B6 G516T in ethnic Chinese persons.

Authors:  Kenneth Tong; Ming-Liang He; Che-Kit Lin; Liping Guo; Hsiang-Fu Kung; Joseph J Y Sung; Shui-Shan Lee
Journal:  Clin Infect Dis       Date:  2006-08-15       Impact factor: 9.079

2.  A natural CYP2B6 TATA box polymorphism (-82T--> C) leading to enhanced transcription and relocation of the transcriptional start site.

Authors:  Jörg Zukunft; Thomas Lang; Tanja Richter; Karen I Hirsch-Ernst; Andreas K Nussler; Kathrin Klein; Matthias Schwab; Michel Eichelbaum; Ulrich M Zanger
Journal:  Mol Pharmacol       Date:  2005-02-18       Impact factor: 4.436

3.  Prevalence of CYP2B6 alleles in malaria-endemic populations of West Africa and Papua New Guinea.

Authors:  Rajeev K Mehlotra; Mark N Ziats; Moses J Bockarie; Peter A Zimmerman
Journal:  Eur J Clin Pharmacol       Date:  2006-02-28       Impact factor: 2.953

4.  Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression.

Authors:  Vishal Lamba; Jatinder Lamba; Kazuto Yasuda; Stephen Strom; Julio Davila; Michael L Hancock; James D Fackenthal; Peter K Rogan; Barbara Ring; Steven A Wrighton; Erin G Schuetz
Journal:  J Pharmacol Exp Ther       Date:  2003-10-09       Impact factor: 4.030
  4 in total
  2 in total

Review 1.  CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.

Authors:  Hongbing Wang; Leslie M Tompkins
Journal:  Curr Drug Metab       Date:  2008-09       Impact factor: 3.731

Review 2.  Insights into CYP2B6-mediated drug-drug interactions.

Authors:  William D Hedrich; Hazem E Hassan; Hongbing Wang
Journal:  Acta Pharm Sin B       Date:  2016-08-09       Impact factor: 11.413
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.